Gilead, looking for cancer sales, swipes Roche pharma chief Daniel O'Day for CEO post
Dec 10, 2018 - FiercePharma
With Gilead's CEO on the way out and revenues tumbling, the company needs a leader who can pump up cancer sales. And it may have found just that in the ranks of the world's biggest cancer drug maker.
The Big Biotech has poached longtime Roche exec Daniel O'Day, who'll take the helm at Gilead on March 1. O'Day heads up pharma operations for the Swiss drugmaker, which has long led the industry in the oncology sales department.
RELATED: Gilead's top executives Milligan and Martin steppi...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
